The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled study.
David Josef Maria BauerLarissa NixdorfNina DominikMichael SchwarzBenedikt Silvester HoferLukas HartlGeorg SemmlerMathias JachsBenedikt SimbrunnerJulia JedamzikBehrang MozayaniLisa GensthalerDaniel Moritz FelsenreichMichael TraunerFelix Benedikt LangerMattias MandorferGerhard PragerThomas ReibergerPublished in: Alimentary pharmacology & therapeutics (2024)
pSWE- and 2D-SWE enable the non-invasive identification of advanced fibrosis and cirrhosis in patients with obese MASLD. The use of the DAX transducer for acoustic radiation force imaging (ARFI)-LSM avoids technical failures in an obese population and subsequently offers advantages over VCTE-LSM for the evaluation of fibrosis in an obese MASLD population at risk for fibrosis.
Keyphrases
- liver fibrosis
- weight loss
- metabolic syndrome
- adipose tissue
- type diabetes
- bariatric surgery
- insulin resistance
- obese patients
- high resolution
- ultrasound guided
- magnetic resonance imaging
- single molecule
- computed tomography
- weight gain
- physical activity
- mass spectrometry
- photodynamic therapy
- skeletal muscle
- high fat diet induced
- contrast enhanced ultrasound